Ann G Hayes

Title: **Inventor Spotlight: Ann G Hayes**

Introduction

Ann G Hayes is a distinguished inventor based in Potters Bar, Great Britain. With a focus on pharmaceutical innovations, she has made significant contributions to the field, registering two patents that showcase her commitment to advancing medical science.

Latest Patents

Among her latest patents, Hayes has developed spiropiperidine derivatives, which consist of compounds represented by a specific formula. These compounds have been disclosed for their potential use in protecting mammals against neuronal damage due to cerebral ischaemia. The preferred compound identified in her patent is (±)-trans-5-fluoro-2,3,3a,9a-tetrahydro-1H-[1,4]-benzodioxino[2,3-c]-pyrrole, particularly effective in its hydrochloride salt form. This innovation serves to aid in the treatment and prevention of conditions associated with cerebral ischaemia, marking a significant step in therapeutic advancements.

Career Highlights

Ann G Hayes is affiliated with Glaxo Group Limited, a renowned company in the pharmaceutical industry that is known for its commitment to healthcare and innovation. Her work contributes to the company's mission of improving health and well-being through groundbreaking research and development.

Collaborations

Throughout her career, Hayes has collaborated with notable colleagues, including Norman F Hayes and David I Scopes. These partnerships have enabled her to leverage diverse expertise and insights, fostering innovation and enhancing the effectiveness of her research efforts.

Conclusion

Ann G Hayes exemplifies the spirit of innovation in the pharmaceutical sector. Her patents and collaborative work reflect her dedication to enhancing medical treatments and protecting neuronal health. As she continues to push the boundaries of research, her contributions are sure to have a lasting impact on the field.